1
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
Condition(s):Bulimia Nervosa; Body Dysmorphic DisorderLast Updated:May 4, 2015Completed
Anti-Glutamatergic: 14 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Riluzole to Treat Parkinson’s Disease
Condition(s):Parkinson’s DiseaseLast Updated:March 4, 2008Completed
3
Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders
Condition(s):Obsessive-Compulsive Disorder; Autism Spectrum Disorder; Autism; Asperger Disorder; Developmental DisorderLast Updated:July 15, 2014Completed
4
Riluzole to Treat Depression in Bipolar Disorder
Condition(s):Bipolar DisorderLast Updated:April 25, 2019Terminated
5
Riluzole to Treat Major Depression
Condition(s):DepressionLast Updated:March 4, 2008Completed
6
Riluzole Effects on Hippocampus Biomarkers
Condition(s):Posttraumatic Stress DisorderLast Updated:November 16, 2020Completed
7
The Effect of Acute Minocycline Administration on Emotional Processing and Cognition in Healthy Volunteers
Condition(s):Mood; Cognitive ChangeLast Updated:April 18, 2019Completed
8
Glutamate Inhibitors in Glioblastoma
Condition(s):GlioblastomaLast Updated:December 23, 2022Not yet recruiting
9
Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:
Condition(s):Major Depressive Disorder; Treatment Resistant Depression; Bipolar DepressionLast Updated:September 14, 2022Enrolling by invitation
10
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
Condition(s):Borderline Personality Disorder; Self-Injurious BehaviorLast Updated:April 15, 2020Terminated